{"id":75903,"date":"2026-10-06T03:24:10","date_gmt":"2026-10-06T03:24:10","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=75903"},"modified":"2026-10-06T15:10:58","modified_gmt":"2026-10-06T15:10:58","slug":"u-s-analyst-updates-october-5th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/","title":{"rendered":"U.S. Analyst Updates: October 5th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/a><\/h2>\n

Today’s analyst updates suggest a cautiously positive market outlook, with support for technology, financials, and selected consumer stocks. Downgrades in materials and parts of the automotive sector point to uneven confidence in cyclical industries. Overall, analysts favour selective opportunities, with earnings growth and valuation remaining central to the outlook.<\/p>\n

Updates (469)<\/strong><\/h3>\n

5E Advanced Materials (FEAM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and raised its price target to $6.75 from $3.50.<\/p>\n

Adtalem Global Education (CVSA)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $145.00 from $148.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to $700.00 from $635.00.<\/p>\n

AECOM (ACM)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $75.00 from $85.00.<\/p>\n

Aercap (AER)<\/strong> \u2014 Truist Securities set a price target of $180.00.<\/p>\n

Aether (ATHR)<\/strong> \u2014 Ascendiant Capital Markets initiated coverage with a Buy rating and a $10.00 price target.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to $146.00 from $135.00.<\/p>\n

Agenus (AGEN)<\/strong> \u2014 Chardan Capital maintained its Buy rating with a $40.00 price target.<\/p>\n

Air Products and Chemicals (APD)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $305.00 from $336.00.<\/p>\n

Albemarle (ALB)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $150.00 from $175.00.<\/p>\n

Align Technology (ALGN)<\/strong> \u2014 Evercore ISI downgraded its rating to In-Line from Outperform with a $155.00 price target.<\/p>\n

Align Technology (ALGN)<\/strong> \u2014 Raymond James maintained its Buy rating.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $50.00 from $54.00.<\/p>\n

Alpha and Omega Semiconductor (AOSL)<\/strong> \u2014 Stifel maintained its Hold rating and lowered its price target to $34.00 from $38.00.<\/p>\n

Alumis (ALMS)<\/strong> \u2014 Benchmark maintained its Buy rating.<\/p>\n

Alumis (ALMS)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 TD Cowen maintained its Buy rating with a $350.00 price target.<\/p>\n

Ambiq Micro (AMBQ)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to $85.00 from $75.00.<\/p>\n

American Express (AXP)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $342.00 from $364.00.<\/p>\n

American Express (AXP)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $345.00 from $384.00.<\/p>\n

Ameriprise Financial (AMP)<\/strong> \u2014 BofA Securities maintained its Buy rating with a $570.00 price target.<\/p>\n

AMETEK (AME)<\/strong> \u2014 Baird maintained its Neutral rating and raised its price target to $280.00 from $275.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating.<\/p>\n

Amrize (AMRZ)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $35.00 from $48.00.<\/p>\n

Amrize (AMRZ)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $40.00 from $44.00.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $88.00 from $97.00.<\/p>\n

Antero Resources (AR)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $46.00 from $52.00.<\/p>\n

Applied Aerospace & Defense (AADX)<\/strong> \u2014 Jefferies set a price target of $20.00.<\/p>\n

ArcelorMittal (MT)<\/strong> \u2014 Deutsche Bank set a price target of $79.00.<\/p>\n

Ardagh Metal Packaging (AMBP)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $4.50 from $5.00.<\/p>\n

Asbury Automotive Group (ABG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $184.00 from $230.00.<\/p>\n

Ashland (ASH)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $80.00 from $83.00.<\/p>\n

Associated Banc (ASB)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $35.00 from $34.00.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 William Blair maintained its Market Perform rating.<\/p>\n

Atlantic Union Bankshares (AUB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $44.00 from $48.00.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to $20.00 from $22.00.<\/p>\n

AutoNation (AN)<\/strong> \u2014 Morgan Stanley downgraded its rating to Equal Weight from Overweight and lowered its price target to $175.00 from $250.00.<\/p>\n

Avidia Bancorp (AVBC)<\/strong> \u2014 Hovde Group initiated coverage with an Outperform rating and a $26.00 price target.<\/p>\n

Axalta Coating Systems (AXTA)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating.<\/p>\n

Axalta Coating Systems (AXTA)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $36.00 from $39.00.<\/p>\n

AxoGen (AXGN)<\/strong> \u2014 Lake Street Capital maintained its Buy rating.<\/p>\n

Axos Financial (AX)<\/strong> \u2014 Needham maintained its Buy rating with a $128.00 price target.<\/p>\n

Ball (BALL)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $63.00 from $66.00.<\/p>\n

Banc of California (BANC)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $23.00 from $22.00.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $67.00 from $70.00.<\/p>\n

Bank of New York Mellon (BNY)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $160.00 from $172.00.<\/p>\n

Bank OZK (OZK)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $50.00 from $52.00.<\/p>\n

Baxter International (BAX)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $27.00 from $28.00.<\/p>\n

BETA Technologies (BETA)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a $31.00 price target.<\/p>\n

Boston Scientific (BSX)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $48.00 from $50.00.<\/p>\n

BP (BP)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n

BP (BP)<\/strong> \u2014 Evercore ISI upgraded its rating to Outperform.<\/p>\n

BP (BP)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $56.00 from $53.00.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Braze (BRZE)<\/strong> \u2014 Citizens maintained its Market Outperform rating with a $35.00 price target.<\/p>\n

Bread Financial (BFH)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $110.00 from $109.00.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 Jefferies maintained its Buy rating.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

Bright Horizons Family Solutions (BFAM)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $83.00 from $93.00.<\/p>\n

BrightSpire Capital (BRSP)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $4.00 from $6.00.<\/p>\n

Bristol Myers Squibb (BMY)<\/strong> \u2014 Leerink Partners downgraded its rating to Market Perform from Outperform and lowered its price target to $59.00 from $73.00.<\/p>\n

Brookfield Asset Management (BAM)<\/strong> \u2014 BofA Securities maintained its Neutral rating and lowered its price target to $60.00 from $61.00.<\/p>\n

C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $198.00 from $225.00.<\/p>\n

Cabot (CBT)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $86.00 from $92.00.<\/p>\n

CAMP4 Therapeutics (CAMP)<\/strong> \u2014 Oppenheimer initiated coverage with an Outperform rating and a $15.00 price target.<\/p>\n

Camping World (CWH)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $237.00 from $240.00.<\/p>\n

CareTrust REIT (CTRE)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $45.00 from $47.00.<\/p>\n

CareTrust REIT (CTRE)<\/strong> \u2014 Raymond James maintained its Outperform rating and lowered its price target to $42.00 from $45.00.<\/p>\n

CareTrust REIT (CTRE)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating with a $43.00 price target.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $48.00 from $58.00.<\/p>\n

Caterpillar (CAT)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $1,100.00 from $1,225.00.<\/p>\n

Cboe Global Markets (CBOE)<\/strong> \u2014 TD Cowen upgraded its rating to Buy from Hold with a $334.00 price target.<\/p>\n

Cerebras Systems (CBRS)<\/strong> \u2014 Jefferies upgraded its rating to Outperform.<\/p>\n

CervoMed (CRVO)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

CF Industries (CF)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating with a $115.00 price target.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 BofA Securities maintained its Underperform rating and raised its price target to $95.00 from $91.00.<\/p>\n

Chemours (CC)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $16.00 from $18.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $179.00 from $175.00.<\/p>\n

Church & Dwight (CHD)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $105.00 from $110.00.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Citigroup downgraded its rating to Market Perform from Market Outperform.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 UBS set a price target of $77.00.<\/p>\n

Climb Bio (CLYM)<\/strong> \u2014 Raymond James maintained its Strong-Buy rating with a $34.00 price target.<\/p>\n

Clorox (CLX)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $85.00 from $90.00.<\/p>\n

Cloudflare (NET)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating with a $340.00 price target.<\/p>\n

CME Group (CME)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $300.00 from $292.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 UBS maintained its Neutral rating and raised its price target to $270.00 from $260.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to $17.00 from $15.00.<\/p>\n

Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $115.00 from $120.00.<\/p>\n

CocaCola (KO)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $90.00 from $95.00.<\/p>\n

Cognex (CGNX)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $74.00 from $78.00.<\/p>\n

Cognition Therapeutics (CGTX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

Coinbase Global (COIN)<\/strong> \u2014 BofA Securities maintained its Buy rating.<\/p>\n

Colgate-Palmolive (CL)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $90.00 from $95.00.<\/p>\n

Columbia Banking System (COLB)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $32.00 from $30.00.<\/p>\n

Columbia Banking System (COLB)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $32.00 from $34.00.<\/p>\n

Commerce Bancshares (CBSH)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $63.00 from $66.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating and raised its price target to $160.00 from $130.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $140.00 from $170.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $201.00 from $196.00.<\/p>\n

Corteva (CTVA)<\/strong> \u2014 New Street Research set a price target of $17.00.<\/p>\n

Corteva (CTVA)<\/strong> \u2014 Oppenheimer set a price target of $17.00.<\/p>\n

Coursera (COUR)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $6.00 from $8.00.<\/p>\n

Covenant Logistics Group (CVLG)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $42.00 from $43.00.<\/p>\n

Credo Technology Group (CRDO)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to $310.00 from $350.00.<\/p>\n

CRH (CRH)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $105.00 from $130.00.<\/p>\n

CRH (CRH)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $106.00 from $107.00.<\/p>\n

Critical Metals (CRML)<\/strong> \u2014 UBS set a price target of $20.00.<\/p>\n

Crown (CCK)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $116.00 from $123.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $57.00 from $58.00.<\/p>\n

Cullen\/Frost Bankers (CFR)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $175.00 from $160.00.<\/p>\n

Cullen\/Frost Bankers (CFR)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $178.00 from $185.00.<\/p>\n

Cummins (CMI)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $779.00 from $894.00.<\/p>\n

Customers Bancorp (CUBI)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $91.00 from $94.00.<\/p>\n

Cyclerion Therapeutics (KRSA)<\/strong> \u2014 Wedbush initiated coverage with an Outperform rating and a $44.00 price target.<\/p>\n

Danaher (DHR)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to $250.00 from $215.00.<\/p>\n

Domino’s Pizza (DPZ)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $325.00 from $350.00.<\/p>\n

Domino’s Pizza (DPZ)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

DoorDash (DASH)<\/strong> \u2014 Wells Fargo maintained its Cautious rating and raised its price target to $230.00 from $225.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 BofA Securities upgraded its rating to Buy from Neutral with a $27.00 price target.<\/p>\n

DTE Energy (DTE)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and raised its price target to $134.00 from $132.00.<\/p>\n

DuPont de Nemours (DD)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $172.00 from $178.00.<\/p>\n

Eagle Materials (EXP)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $188.00 from $196.00.<\/p>\n

Eastern Bankshares (EBC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $23.00 from $22.00.<\/p>\n

Eastern Bankshares (EBC)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $25.00 from $26.00.<\/p>\n

Eastman Chemical (EMN)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $77.00 from $92.00.<\/p>\n

Ecolab (ECL)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $344.00 from $342.00.<\/p>\n

Edgewell Personal Care (EPC)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $30.00 from $32.00.<\/p>\n

Edwards Lifesciences (EW)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Elbit Systems (ESLT)<\/strong> \u2014 Jefferies maintained its Hold rating with a $790.00 price target.<\/p>\n

Element Solutions (ESI)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $48.00 from $47.00.<\/p>\n

ENI (E)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n

Enovis (ENOV)<\/strong> \u2014 UBS maintained its Buy rating with a $44.00 price target.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Oppenheimer maintained its Outperform rating with a $55.00 price target.<\/p>\n

EquipmentShare.com (EQPT)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $31.00 from $35.00.<\/p>\n

Ermenegildo Zegna (ZGN)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $15.40 from $15.50.<\/p>\n

Essent Group (ESNT)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $66.00 from $65.00.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Barclays upgraded its rating to Overweight from Equal Weight and raised its price target to $108.00 from $97.00.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $95.00 from $104.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 BofA Securities maintained its Neutral rating.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 Raymond James maintained its Strong-Buy rating and lowered its price target to $141.00 from $147.00.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating and lowered its price target to $127.00 from $160.00.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $120.00 from $121.00.<\/p>\n

Expeditors International of Washington (EXPD)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to $214.00 from $200.00.<\/p>\n

Federal Realty Investment Trust (FRT)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $126.00 from $134.00.<\/p>\n

FedEx (FDX)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $399.00 from $400.00.<\/p>\n

FedEx Freight (FDXF)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $149.00 from $160.00.<\/p>\n

Ferrari (RACE)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $450.00 from $490.00.<\/p>\n

Fidelity National Financial (FNF)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $47.00 from $54.00.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 UBS set a price target of $63.00.<\/p>\n

Figure Technology Solutions (FIGR)<\/strong> \u2014 BofA Securities maintained its Neutral rating with a $44.00 price target.<\/p>\n

First American Financial (FAF)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $79.00 from $83.00.<\/p>\n

First Hawaiian (FHB)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $28.00 from $31.00.<\/p>\n

First Interstate BancSystem (FIBK)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $38.00 from $37.00.<\/p>\n

First Merchants (FRME)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $46.00 from $51.00.<\/p>\n

Flagstar Bank, National Association (FLG)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $15.00 from $17.00.<\/p>\n

Flagstar Bank, National Association (FLG)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $16.00 from $17.00.<\/p>\n

FMC (FMC)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $10.00 from $12.00.<\/p>\n

Forbright (FRBT)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $24.00 from $23.00.<\/p>\n

FormFactor (FORM)<\/strong> \u2014 Freedom Capital Markets maintained its Hold rating and raised its price target to $140.00 from $64.00.<\/p>\n

Fortive (FTV)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $63.00 from $68.00.<\/p>\n

Freeport-McMoRan (FCX)<\/strong> \u2014 Citigroup maintained its Buy rating and raised its price target to $84.00 from $66.00.<\/p>\n

Freshpet (FRPT)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

Freshpet (FRPT)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $77.00 from $82.00.<\/p>\n

Gain Therapeutics (GANX)<\/strong> \u2014 BTIG maintained its Buy rating with a $5.00 price target.<\/p>\n

Gain Therapeutics (GANX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $8.00 price target.<\/p>\n

Gartner (IT)<\/strong> \u2014 UBS maintained its Neutral rating and raised its price target to $208.00 from $196.00.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $71.00 from $75.00.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 Needham maintained its Buy rating with a $93.00 price target.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating.<\/p>\n

Generac (GNRC)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $297.00 from $333.00.<\/p>\n

Generate Biomedicines (GENB)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $30.00 price target.<\/p>\n

Genmab A\/S (GMAB)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to $54.00 from $45.00.<\/p>\n

GlobalFoundries (GFS)<\/strong> \u2014 BNP Paribas Exane downgraded its rating to Neutral from Outperform with a $51.00 price target.<\/p>\n

Globe Life (GL)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $197.00 from $208.00.<\/p>\n

Grand Canyon Education (LOPE)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $182.00 from $185.00.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $9.50 from $12.00.<\/p>\n

Group 1 Automotive (GPI)<\/strong> \u2014 Morgan Stanley downgraded its rating to Underweight from Equal Weight and lowered its price target to $232.00 from $300.00.<\/p>\n

Grupo Aeroportuario Del Pacifico (PAC)<\/strong> \u2014 HSBC upgraded its rating to Buy from Hold with a $277.00 price target.<\/p>\n

Grupo Aeroportuario Del Pacifico (PAC)<\/strong> \u2014 HSBC Securities upgraded its rating to Buy from Hold with a $277.00 price target.<\/p>\n

Hancock Whitney (HWC)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $85.00 from $82.00.<\/p>\n

Harley-Davidson (HOG)<\/strong> \u2014 Citigroup upgraded its rating to Buy from Neutral and raised its price target to $33.00 from $31.00.<\/p>\n

Harley-Davidson (HOG)<\/strong> \u2014 Evercore ISI upgraded its rating to Outperform from Underperform with a $33.00 price target.<\/p>\n

Helmerich & Payne (HP)<\/strong> \u2014 Susquehanna maintained its Positive rating and raised its price target to $50.00 from $44.00.<\/p>\n

Hermes International (HESAY)<\/strong> \u2014 Goldman Sachs initiated coverage with a Sell rating.<\/p>\n

Hermes International (HESAY)<\/strong> \u2014 UBS downgraded its rating to Sell from Neutral.<\/p>\n

Hershey (HSY)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $170.00 from $190.00.<\/p>\n

HF Sinclair (DINO)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $133.00 from $126.00.<\/p>\n

Hub Group (HUBG)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $46.00 from $50.00.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 Raymond James downgraded its rating to Market Perform from Outperform.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 UBS downgraded its rating to Market Perform from Sector Perform.<\/p>\n

Huntington Bancshares (HBAN)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $19.00 from $22.00.<\/p>\n

Huntsman (HUN)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $9.00 from $10.00.<\/p>\n

Illinois Tool Works (ITW)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $297.00 from $308.00.<\/p>\n

Illumina (ILMN)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to $310.00 from $230.00.<\/p>\n

Incyte (INCY)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to $157.00 from $145.00.<\/p>\n

Incyte (INCY)<\/strong> \u2014 UBS maintained its Neutral rating with a $127.00 price target.<\/p>\n

Ingredion (INGR)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $104.00 from $108.00.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $15.00 from $18.00.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $15.00 from $19.00.<\/p>\n

Interactive Brokers Group (IBKR)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to $116.00 from $114.00.<\/p>\n

Intercontinental Exchange (ICE)<\/strong> \u2014 TD Cowen downgraded its rating to Hold from Buy and lowered its price target to $166.00 from $177.00.<\/p>\n

International Paper (IP)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $35.00 from $47.00.<\/p>\n

International Seaways (INSW)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and raised its price target to $140.00 from $120.00.<\/p>\n

iRhythm Technologies (IRTC)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to $194.00 from $192.00.<\/p>\n

ITG (ITG)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $14.00 from $17.00.<\/p>\n

J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $287.00 from $313.00.<\/p>\n

J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $283.00 from $297.00.<\/p>\n

J.Jill (JILL)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to $25.00 from $22.00.<\/p>\n

Jacobs Solutions (J)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $160.00 from $161.00.<\/p>\n

Johnson & Johnson (JNJ)<\/strong> \u2014 Citigroup maintained its Buy rating and raised its price target to $303.00 from $298.00.<\/p>\n

JPMorgan Chase & Co. (JPM)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $395.00 from $400.00.<\/p>\n

KB Home (KBH)<\/strong> \u2014 Keefe Bruyette & Woods maintained its Market Perform rating and lowered its price target to $54.00 from $65.00.<\/p>\n

KeyCorp (KEY)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $25.00 from $27.00.<\/p>\n

Kimberly-Clark (KMB)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $100.00 from $105.00.<\/p>\n

KinderCare Learning Companies (KLC)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $4.00 from $5.00.<\/p>\n

Knife River (KNF)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $54.00 from $62.00.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $68.00 from $84.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $67.00 from $72.00.<\/p>\n

Kraft Heinz (KHC)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $23.00 from $25.00.<\/p>\n

Kura Oncology (KURA)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

Kymera Therapeutics (KYMR)<\/strong> \u2014 Citigroup maintained its Buy rating and raised its price target to $150.00 from $135.00.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $385.00 from $367.00.<\/p>\n

Lamb Weston (LW)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $54.00 from $57.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $181.00 from $204.00.<\/p>\n

LB Pharmaceuticals (LBRX)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating and a $80.00 price target.<\/p>\n

LB Pharmaceuticals (LBRX)<\/strong> \u2014 Roth Capital downgraded its rating to Neutral from Buy and lowered its price target to $35.00 from $37.00.<\/p>\n

LifeStance Health Group (LFST)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and raised its price target to $15.00 from $13.00.<\/p>\n

Lincoln National (LNC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $47.00 from $50.00.<\/p>\n

Linde (LIN)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating.<\/p>\n

Linde (LIN)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $574.00 from $612.00.<\/p>\n

Lithia Motors (LAD)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $310.00 from $358.00.<\/p>\n

Live Oak Bancshares (LOB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $44.00 from $49.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 BofA Securities maintained its Buy rating and lowered its price target to $554.00 from $557.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Citizens maintained its Market Outperform rating with a $500.00 price target.<\/p>\n

Lsb Industries (LXU)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating with a $13.00 price target.<\/p>\n

Lumentum (LITE)<\/strong> \u2014 Rosenblatt maintained its Buy rating with a $1,300.00 price target.<\/p>\n

Lumentum (LITE)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to $1,232.00 from $1,100.00.<\/p>\n

Lumexa Imaging (LMRI)<\/strong> \u2014 Truist Securities initiated coverage with a Buy rating and a $18.00 price target.<\/p>\n

Lyft (LYFT)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $17.00 from $19.00.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $238.00 from $255.00.<\/p>\n

Maplebear (CART)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to $56.00 from $54.00.<\/p>\n

Maplight Therapeutics (MPLT)<\/strong> \u2014 Guggenheim initiated coverage with a Neutral rating.<\/p>\n

Maravai LifeSciences (MRVI)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and a $9.00 price target.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $625.00 from $730.00.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $579.00 from $585.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $320.00 from $420.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $380.00 from $428.00.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 Guggenheim maintained its Neutral rating and lowered its price target to $250.00 from $290.00.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $270.00 from $300.00.<\/p>\n

Merchants Bancorp (MBIN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $63.00 from $64.00.<\/p>\n

Merck & Co., Inc. (MRK)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to $165.00 from $150.00.<\/p>\n

Methanex (MEOH)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $74.00 from $71.00.<\/p>\n

MetLife (MET)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $110.00 from $105.00.<\/p>\n

MGIC Investment (MTG)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $29.00 from $28.00.<\/p>\n

MGP Ingredients (MGPI)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $17.00 from $22.00.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Melius Research upgraded its rating to Buy from Hold with a $665.00 price target.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and raised its price target to $615.00 from $510.00.<\/p>\n

Millrose Properties (MRP)<\/strong> \u2014 Citizens downgraded its rating to Market Perform from Market Outperform.<\/p>\n

Molson Coors Beverage (TAP)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $38.00 from $41.00.<\/p>\n

Mondelez International (MDLZ)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $65.00 from $70.00.<\/p>\n

Monolithic Power Systems (MPWR)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

Monster Beverage (MNST)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $48.00 from $53.00.<\/p>\n

Monte Rosa Therapeutics (GLUE)<\/strong> \u2014 Benchmark maintained its Buy rating.<\/p>\n

Monte Rosa Therapeutics (GLUE)<\/strong> \u2014 Raymond James set a price target of $25.00.<\/p>\n

MoonLake Immunotherapeutics (MLTX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $50.00 price target.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $236.00 from $260.00.<\/p>\n

Mosaic (MOS)<\/strong> \u2014 RBC Capital Markets downgraded its rating to Sector Perform from Outperform and lowered its price target to $25.00 from $27.00.<\/p>\n

Nabors Industries (NBR)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to $91.00 from $85.00.<\/p>\n

National Bank (NBHC)<\/strong> \u2014 DA Davidson maintained its Buy rating and lowered its price target to $43.00 from $45.00.<\/p>\n

Navient (NAVI)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $7.00 from $8.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 TD Cowen maintained its Buy rating with a $100.00 price target.<\/p>\n

NETGEAR (NTGR)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to $30.00 from $36.00.<\/p>\n

NewAmsterdam Pharma (NAMS)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to $42.00 from $50.00.<\/p>\n

NIKE (NKE)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $37.00 from $48.00.<\/p>\n

Noble (NE)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to $44.00 from $40.00.<\/p>\n

Nordic American Tankers (NAT)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and raised its price target to $10.00 from $8.00.<\/p>\n

Norfolk Southern (NSC)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $318.00 from $338.00.<\/p>\n

Northern Trust (NTRS)<\/strong> \u2014 Citigroup maintained its Neutral rating and raised its price target to $186.00 from $182.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to $286.00 from $288.00.<\/p>\n

Nutrien (NTR)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating with a $85.00 price target.<\/p>\n

nVent Electric (NVT)<\/strong> \u2014 BMO Capital Markets initiated coverage with an Outperform rating and a $212.00 price target.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating with a $345.00 price target.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Stifel maintained its Hold rating and lowered its price target to $265.00 from $282.00.<\/p>\n

O-I Glass (OI)<\/strong> \u2014 UBS downgraded its rating to Neutral from Buy and lowered its price target to $6.00 from $11.00.<\/p>\n

Oil States International (OIS)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to $9.00 from $8.00.<\/p>\n

Okeanis Eco Tankers (ECO)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and raised its price target to $100.00 from $75.00.<\/p>\n

Old Dominion Freight Line (ODFL)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $232.00 from $250.00.<\/p>\n

Old National Bancorp (ONB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $30.00 from $31.00.<\/p>\n

Olin (OLN)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $18.00 from $21.00.<\/p>\n

Ondas (ONDS)<\/strong> \u2014 Citigroup initiated coverage with a Market Outperform rating.<\/p>\n

Ondas (ONDS)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a $14.00 price target.<\/p>\n

onsemi (ON)<\/strong> \u2014 Stifel maintained its Hold rating and raised its price target to $80.00 from $75.00.<\/p>\n

Orchestra BioMed (OBIO)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $10.00 price target.<\/p>\n

Oric Pharmaceuticals (ORIC)<\/strong> \u2014 Leerink Partners initiated coverage with an Outperform rating and a $26.00 price target.<\/p>\n

Orion (OEC)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $6.50 from $8.00.<\/p>\n

Oshkosh (OSK)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $174.00 from $196.00.<\/p>\n

Ovid Therapeutics (OVID)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating and a $7.00 price target.<\/p>\n

Oxford Industries (OXM)<\/strong> \u2014 BTIG maintained its Neutral rating.<\/p>\n

PACCAR (PCAR)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $125.00 from $139.00.<\/p>\n

Packaging Corporation of America (PKG)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $289.00 from $292.00.<\/p>\n

PBF Energy (PBF)<\/strong> \u2014 UBS maintained its Buy rating with a $99.00 price target.<\/p>\n

PennyMac Financial Services (PFSI)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $71.00 from $85.00.<\/p>\n

Peoples Bancorp (PEBO)<\/strong> \u2014 Keefe Bruyette & Woods maintained its Market Perform rating.<\/p>\n

Peoples Bancorp (PEBO)<\/strong> \u2014 Piper Sandler set a price target of $42.00.<\/p>\n

PepsiCo (PEP)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $135.00 from $140.00.<\/p>\n

Pershing Square (PS)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to $44.00 from $41.00.<\/p>\n

Phillips Edison & Company, Inc. (PECO)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $41.00 from $43.00.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $33.00 from $36.00.<\/p>\n

Pinnacle Financial Partners (PNFP)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $115.00 from $119.00.<\/p>\n

Pinnacle West Capital (PNW)<\/strong> \u2014 Jefferies maintained its Buy rating and lowered its price target to $109.00 from $129.00.<\/p>\n

Pinnacle West Capital (PNW)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $99.00 from $101.00.<\/p>\n

Planet Fitness (PLNT)<\/strong> \u2014 Baird maintained its Outperform rating and lowered its price target to $60.00 from $72.00.<\/p>\n

Planet Fitness (PLNT)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to $60.00 from $65.00.<\/p>\n

Popular (BPOP)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $205.00 from $200.00.<\/p>\n

Post (POST)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $79.00 from $86.00.<\/p>\n

Power Integrations (POWI)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to $72.00 from $80.00.<\/p>\n

PPG Industries (PPG)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $116.00 from $125.00.<\/p>\n

Procore Technologies (PCOR)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a $65.00 price target.<\/p>\n

Progressive (PGR)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to $250.00 from $241.00.<\/p>\n

Prosperity Bancshares (PB)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $70.00 from $68.00.<\/p>\n

Prosperity Bancshares (PB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $78.00 from $84.00.<\/p>\n

PTC (PTC)<\/strong> \u2014 Barclays downgraded its rating to Equal Weight from Overweight with a $205.00 price target.<\/p>\n

PTC (PTC)<\/strong> \u2014 Deutsche Bank downgraded its rating to Hold with a $205.00 price target.<\/p>\n

PTC (PTC)<\/strong> \u2014 KeyBanc Capital Markets downgraded its rating to Sector Weight from Overweight.<\/p>\n

PTC (PTC)<\/strong> \u2014 Loop Capital downgraded its rating to Hold from Buy and raised its price target to $205.00 from $200.00.<\/p>\n

PTC (PTC)<\/strong> \u2014 RBC Capital Markets downgraded its rating to Sector Perform from Buy and raised its price target to $306.00 from $195.00.<\/p>\n

PTC (PTC)<\/strong> \u2014 Rosenblatt downgraded its rating to Neutral from Buy with a $205.00 price target.<\/p>\n

PTC (PTC)<\/strong> \u2014 Stifel set a price target of $205.00.<\/p>\n

QT Imaging (QTI)<\/strong> \u2014 Craig-Hallum initiated coverage with a Buy rating and a $8.00 price target.<\/p>\n

Quanta Services (PWR)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a $862.00 price target.<\/p>\n

Quanta Services (PWR)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $945.00 from $976.00.<\/p>\n

Radian Group (RDN)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $36.00 from $35.00.<\/p>\n

Range Resources (RRC)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating.<\/p>\n

Range Resources (RRC)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to $43.00 from $45.00.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 Guggenheim maintained its Buy rating with a $65.00 price target.<\/p>\n

Raymond James Financial (RJF)<\/strong> \u2014 BofA Securities maintained its Neutral rating and raised its price target to $198.00 from $196.00.<\/p>\n

Raymond James Financial (RJF)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to $185.00 from $179.00.<\/p>\n

Rayonier (RYN)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $19.00 from $23.00.<\/p>\n

Regency Centers (REG)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $87.00 from $88.00.<\/p>\n

REGENXBIO (RGNX)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a $22.00 price target.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $30.00 from $33.00.<\/p>\n

Reliance (RS)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and raised its price target to $421.00 from $418.00.<\/p>\n

Renasant (RNST)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $46.00 from $49.00.<\/p>\n

Rentokil Initial (RTO)<\/strong> \u2014 Goldman Sachs maintained its Buy rating.<\/p>\n

Rentokil Initial (RTO)<\/strong> \u2014 Stifel upgraded its rating to Buy from Hold.<\/p>\n

Replimune Group (REPL)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n

Rezolute (RZLT)<\/strong> \u2014 Cantor Fitzgerald upgraded its rating to Overweight from Neutral.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to $156.00 from $140.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Raymond James maintained its Market Perform rating.<\/p>\n

Rocket Companies (RKT)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $15.00 from $17.00.<\/p>\n

Rollins (ROL)<\/strong> \u2014 Citigroup maintained its Underperform rating.<\/p>\n

RPM International (RPM)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $130.00 from $135.00.<\/p>\n

RXO (RXO)<\/strong> \u2014 Jefferies downgraded its rating to Hold from Buy.<\/p>\n

RXO (RXO)<\/strong> \u2014 TD Cowen upgraded its rating to Hold from Sell.<\/p>\n

Ryder System (R)<\/strong> \u2014 JPMorgan upgraded its rating to Overweight from Neutral and raised its price target to $298.00 from $296.00.<\/p>\n

Ryder System (R)<\/strong> \u2014 Morgan Stanley upgraded its rating to Buy from Overweight.<\/p>\n

S&P Global (SPGI)<\/strong> \u2014 Mizuho set a price target of $531.00.<\/p>\n

Sable Offshore (SOC)<\/strong> \u2014 William Blair initiated coverage with an Outperform rating.<\/p>\n

Sagimet Biosciences (SGMT)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $29.00 price target.<\/p>\n

Saia (SAIA)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $463.00 from $490.00.<\/p>\n

SailPoint (SAIL)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and raised its price target to $24.00 from $22.00.<\/p>\n

Samsara (IOT)<\/strong> \u2014 Jefferies initiated coverage with a Buy rating and a $50.00 price target.<\/p>\n

Sarepta Therapeutics (SRPT)<\/strong> \u2014 H.C. Wainwright maintained its Sell rating with a $5.00 price target.<\/p>\n

SBA Communications (SBAC)<\/strong> \u2014 Raymond James maintained its Outperform rating with a $271.00 price target.<\/p>\n

Schneider National (SNDR)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $30.00 from $35.00.<\/p>\n

Scotts Miracle-Gro (SMG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $60.00 from $77.00.<\/p>\n

Semtech (SMTC)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to $220.00 from $188.00.<\/p>\n

Shell (SHEL)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $363.00 from $390.00.<\/p>\n

Shift4 Payments (FOUR)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to $63.00 from $78.00.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

Sight Sciences (SGHT)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Silgan (SLGN)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $38.00 from $47.00.<\/p>\n

Silver Standard Resources (SSRM)<\/strong> \u2014 CIBC maintained its Outperformer rating and raised its price target to $50.00 from $48.00.<\/p>\n

Solstice Advanced Mat (SOLS)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $76.00 from $80.00.<\/p>\n

Sonic Automotive (SAH)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to $57.00 from $72.00.<\/p>\n

Sonoco Products (SON)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $51.00 from $61.00.<\/p>\n

Southern Missouri Bancorp (SMBC)<\/strong> \u2014 Hovde Group initiated coverage with a Market Perform rating and a $76.00 price target.<\/p>\n

SouthState Bank (SSB)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $120.00 from $118.00.<\/p>\n

SouthState Bank (SSB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $116.00 from $120.00.<\/p>\n

Southwest Gas (SWX)<\/strong> \u2014 Jefferies maintained its Buy rating with a $106.00 price target.<\/p>\n

Spectrum Brands (SPB)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $85.00 from $90.00.<\/p>\n

Sphere Entertainment (SPHR)<\/strong> \u2014 Craig-Hallum downgraded its rating to Hold from Buy with a $132.00 price target.<\/p>\n

Spotify Technology (SPOT)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $675.00 from $690.00.<\/p>\n

SPX Technologies (SPXC)<\/strong> \u2014 Baird set a price target of $220.00.<\/p>\n

SPX Technologies (SPXC)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $266.00 from $301.00.<\/p>\n

Spyglass Pharma (SGP)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $37.00 price target.<\/p>\n

Spyglass Pharma (SGP)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

Stagwell (STGW)<\/strong> \u2014 Goldman Sachs resumed coverage with a Buy rating and a $13.00 price target.<\/p>\n

State Street (STT)<\/strong> \u2014 Citigroup maintained its Buy rating and raised its price target to $212.00 from $210.00.<\/p>\n

Strategic Education (STRA)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $95.00 from $100.00.<\/p>\n

Stride (LRN)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $90.00 from $93.00.<\/p>\n

Summit Therapeutics (SMMT)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating.<\/p>\n

Swatch Group (SWGAY)<\/strong> \u2014 Goldman Sachs initiated coverage with a Sell rating.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $81.00 from $87.00.<\/p>\n

T1 Energy (TE)<\/strong> \u2014 Northland Securities set a price target of $9.00.<\/p>\n

Tenaris (TS)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to $71.00 from $66.00.<\/p>\n

Terex (TEX)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $85.00 from $96.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Goldman Sachs upgraded its rating to Buy from Neutral.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 HSBC maintained its Reduce rating with a $157.00 price target.<\/p>\n

Texas Capital Bancshares (TCBI)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $100.00 from $106.00.<\/p>\n

Texas Roadhouse (TXRH)<\/strong> \u2014 Evercore ISI upgraded its rating to Outperform from In-Line with a $200.00 price target.<\/p>\n

Texas Roadhouse (TXRH)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to $220.00 from $235.00.<\/p>\n

TFI International (TFII)<\/strong> \u2014 CIBC maintained its Outperformer rating and lowered its price target to $158.00 from $175.00.<\/p>\n

TFI International (TFII)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $168.00 from $175.00.<\/p>\n

The Goldman Sachs Group (GS)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $1,010.00 from $1,150.00.<\/p>\n

The PNC Financial Services Group (PNC)<\/strong> \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to $250.00 from $281.00.<\/p>\n

Tilray Brands (TLRY)<\/strong> \u2014 TD maintained its Buy rating and lowered its price target to $4.50 from $4.70.<\/p>\n

TotalEnergies (TTE)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n

Tronox (TROX)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $4.50 from $7.00.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $50.00 from $55.00.<\/p>\n

U.S. Bancorp (USB)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $64.00 from $66.00.<\/p>\n

Uber Technologies (UBER)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $92.00 from $89.00.<\/p>\n

Ultra Clean (UCTT)<\/strong> \u2014 UBS maintained its Buy rating with a $135.00 price target.<\/p>\n

UMB Financial (UMBF)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $152.00 from $166.00.<\/p>\n

Union Pacific (UNP)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to $322.00 from $334.00.<\/p>\n

uniQure (QURE)<\/strong> \u2014 Barclays downgraded its rating to Equal Weight from Overweight and lowered its price target to $28.00 from $60.00.<\/p>\n

United Rentals (URI)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $1,395.00 from $1,466.00.<\/p>\n

Unity Software (U)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

Valaris (VAL)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to $86.00 from $80.00.<\/p>\n

Vanda Pharmaceuticals (VNDA)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $20.00 price target.<\/p>\n

Vaxcyte (PCVX)<\/strong> \u2014 BTIG maintained its Buy rating with a $89.00 price target.<\/p>\n

Vaxcyte (PCVX)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to $125.00 from $116.00.<\/p>\n

Vaxcyte (PCVX)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to $122.00 from $110.00.<\/p>\n

Veralto (VLTO)<\/strong> \u2014 UBS maintained its Neutral rating and raised its price target to $106.00 from $104.00.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 BTIG maintained its Buy rating with a $18.00 price target.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a $18.00 price target.<\/p>\n

Vertiv (VRT)<\/strong> \u2014 BMO Capital Markets initiated coverage with an Outperform rating and a $329.00 price target.<\/p>\n

Viatris (VTRS)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to $26.00 from $23.00.<\/p>\n

Virtu Financial (VIRT)<\/strong> \u2014 Evercore ISI upgraded its rating to Outperform.<\/p>\n

Virtu Financial (VIRT)<\/strong> \u2014 JPMorgan upgraded its rating to Overweight from Neutral with a $84.00 price target.<\/p>\n

Vistra (VST)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $210.00 from $231.00.<\/p>\n

Vita Coco (COCO)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $65.00 from $85.00.<\/p>\n

Vulcan Materials (VMC)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to $320.00 from $360.00.<\/p>\n

Vulcan Materials (VMC)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and lowered its price target to $249.00 from $254.00.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 BofA Securities initiated coverage with a Buy rating and a $78.00 price target.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a $84.00 price target.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 Vertical Research initiated coverage with a Buy rating and a $74.00 price target.<\/p>\n

Walt Disney (DIS)<\/strong> \u2014 Raymond James maintained its Outperform rating and lowered its price target to $119.00 from $120.00.<\/p>\n

Wells Fargo & Company (WFC)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to $96.00 from $107.00.<\/p>\n

Wells Fargo & Company (WFC)<\/strong> \u2014 Morgan Stanley upgraded its rating to Overweight from Equal Weight with a $102.00 price target.<\/p>\n

Wells Fargo & Company (WFC)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $102.00 from $104.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 JPMorgan maintained its Underweight rating and lowered its price target to $33.00 from $39.00.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $93.00 from $88.00.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $85.00 from $90.00.<\/p>\n

Westlake (WLK)<\/strong> \u2014 Citigroup maintained its Neutral rating and lowered its price target to $67.00 from $85.00.<\/p>\n

Westlake (WLK)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to $86.00 from $98.00.<\/p>\n

Weyerhaeuser (WY)<\/strong> \u2014 Citigroup maintained its Buy rating and lowered its price target to $21.00 from $29.00.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $190.00 from $192.00.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $195.00 from $186.00.<\/p>\n

Wintrust Financial (WTFC)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $173.00 from $183.00.<\/p>\n

Workday (WDAY)<\/strong> \u2014 Needham maintained its Buy rating with a $230.00 price target.<\/p>\n

WSFS Financial (WSFS)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $89.00 from $92.00.<\/p>\n

XPO (XPO)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to $205.00 from $214.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to $112.00 from $138.00.<\/p>\n

Yesway (YSWY)<\/strong> \u2014 Guggenheim maintained its Buy rating with a $32.00 price target.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Truist Securities maintained its Hold rating and raised its price target to $378.00 from $355.00.<\/p>\n

Zentalis Pharmaceuticals (ZNTL)<\/strong> \u2014 Leerink Partners resumed coverage with an Outperform rating and raised its price target to $8.00 from $4.00.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to $40.00 from $31.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Zions Bancorporation, N.A. (ZION)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to $69.00 from $73.00.<\/p>\n

Zscaler (ZS)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and raised its price target to $240.00 from $200.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Today’s analyst updates suggest a cautiously positive market outlook, with support for technology, financials, and selected consumer stocks. Downgrades in materials…<\/p>\n","protected":false},"author":3,"featured_media":19172,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-75903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nU.S. Analyst Updates: October 5th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Analyst Updates: October 5th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today’s analyst updates suggest a cautiously positive market outlook, with support for technology, financials, and selected consumer stocks. Downgrades in materials…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-06T03:24:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-06T15:10:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2022\/07\/StockTargetAdvisor-Frame-1-9.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"33 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"U.S. Analyst Updates: October 5th, 2026\",\"datePublished\":\"2026-10-06T03:24:10+00:00\",\"dateModified\":\"2026-10-06T15:10:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\"},\"wordCount\":6840,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\",\"name\":\"U.S. Analyst Updates: October 5th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-06T03:24:10+00:00\",\"dateModified\":\"2026-10-06T15:10:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Analyst Updates: October 5th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"U.S. Analyst Updates: October 5th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Analyst Updates: October 5th, 2026","og_description":"Analyst Ratings (USA) Today’s analyst updates suggest a cautiously positive market outlook, with support for technology, financials, and selected consumer stocks. Downgrades in materials…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-06T03:24:10+00:00","article_modified_time":"2026-10-06T15:10:58+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2022\/07\/StockTargetAdvisor-Frame-1-9.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"33 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"U.S. Analyst Updates: October 5th, 2026","datePublished":"2026-10-06T03:24:10+00:00","dateModified":"2026-10-06T15:10:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/"},"wordCount":6840,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/","name":"U.S. Analyst Updates: October 5th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-06T03:24:10+00:00","dateModified":"2026-10-06T15:10:58+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-5th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"U.S. Analyst Updates: October 5th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=75903"}],"version-history":[{"count":8,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75903\/revisions"}],"predecessor-version":[{"id":75920,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75903\/revisions\/75920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/19172"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=75903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=75903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=75903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}